Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.84 | - | - |
| Formycon AG | 3 | 1 | 0 | 0 | €46.40 | €100.00 | 115.517% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.56 | €5.10 | 226.229% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.80 | €50.00 | 39.665% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.89 | €18.30 | 870.095% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.39 | - | - |
| Palisade Bio Inc. | 3 | 1 | 2 | 0 | €0.34 | €21.06 | 6072.333% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.94 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.76 | €30.00 | 986.957% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.56 | - | - |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.11 | €50.00 | 1116.545% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.09 | €3.65 | 236.206% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.36 | €0.000 | -100.000% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.88 | €6.53 | 638.801% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.06 | €3.00 | 45.490% |
| Medigene AG | 0 | 2 | 0 | 0 | €1.40 | €1.00 | -28.571% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 2 | €1.05 | €2.00 | 90.476% |
| Novavax Inc. | 4 | 2 | 1 | 0 | €4.40 | €12.00 | 173.006% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.64 | €3.00 | 372.441% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.92 | €3.00 | 226.087% |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |